BUY Aurobindo Pharma — Prabhudas Lilladher, 27 May 2025

byPrabhudas LilladherHorizon: NA (inferred 1 year)27 May 2025via Institutional / Brokerage Research

Entry₹1,191.2Inferred

Target₹1,440

Stop lossNot given

Exit₹1,44023 Apr 2026, 12:00 am

Target hit+20.89%0.00%upside left

Follow Prabhudas Lilladher for new calls(67% target hit, 412 closed calls)Get alerts Watch AUROPHARMA for new buy/sell callsGet alerts See 10 active Long-term calls on AUROPHARMA

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 4:12 am IST

2 supporting1 neutral0 opposing

Supports the BUY call (2)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·6 Apr · 2w ago

3 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·1 Apr · 3w ago

Neutral / worth noting (1)

Aurobindo Pharma Ltd submitted a Letter of Offer for the buyback of 5,423,728 fully paid-up equity shares.

BSE · Company Update·21 Apr · yesterday

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.